Microglial pannexin-1 channel activation is a spinal determinant of joint pain

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Chronic joint pain, particularly mechanical allodynia, is a major debilitating symptom of arthritis with limited effective treatments.
• Spinal adenosine 5'-triphosphate (ATP) release and microglia-specific up-regulation of P2X7 receptors (P2X7Rs) are implicated in arthritis-induced pain.

Purpose of the Study:

• To identify pannexin-1 (Panx1) as a therapeutic target for alleviating mechanical allodynia in arthritis.
• To elucidate the role of Panx1 channels in spinal microglia in the development of chronic joint pain.

Main Methods:

• Utilized rat models of arthritis induced by monosodium iodoacetate (MIA) injection and anterior cruciate ligament transection.
• Investigated the effects of P2X7R blockade, spinal microglia ablation, and Panx1 channel inhibition (using ¹⁰panx peptide and probenecid) on mechanical allodynia.
• Examined microglia-specific Panx1 genetic deletion in mice and assessed pain behaviors using dynamic weight-bearing tests.

Main Results:

• Blockade of P2X7R or ablation of spinal microglia prevented and reversed mechanical allodynia in arthritic rats.
• Microglial Panx1 channel activation led to interleukin-1β (IL-1β) release, inducing mechanical allodynia.
• Panx1 inhibition with ¹⁰panx suppressed aberrant neuronal discharge, and genetic Panx1 deletion in microglia protected mice from allodynia.
• Probenecid, a Panx1 blocker, significantly attenuated MIA-induced mechanical allodynia and reversed pain in post-traumatic osteoarthritis models.

Conclusions:

• Pannexin-1 (Panx1) channel activation in spinal microglia is a key mechanism driving chronic joint pain in arthritis.
• Targeting Panx1 channels represents a novel and effective therapeutic strategy for alleviating debilitating joint pain associated with arthritis.